Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
do they know 04-Feb-22 RBC Capital Markets Outperform - 1,950.00 Reiteration
I dont care now I am out lol
we need to break the 1362 and 1420 to start going back to where we belong. :-)
we need to stay above 1292 for a few days
The delay is due to the US shareholders, so that they are not at an undue disadvantage.
Results were solid. Growth was as largely predicted. The one good element was the acquisition of BioVision is showing sound reasoning, with a growth rate higher than the existing portfolio.
Planned 2024 performance is inline with expectations, despite the Covid impact that has affected customers over the last 21 months.
Hoping to see a rise from here.
I think they are good see below
27 January 2022
27 January 2022
ABCAM PLC
Trading Update
Cambridge, UK: Abcam plc ("Abcam", "Company", "Group") (AIM: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following trading update ahead of reporting its financial results in March:
The Group expects to report total revenues for the 12 months ended 31 December 2021 of approximately £315 million, representing growth of over 22% on a constant exchange rate (CER) basis and 17% on a reported basis (12 months to 31 December 2020: £269.3 million). This figure includes a contribution of approximately £2.5 million of incremental revenue1 from BioVision following the acquisition's completion on 27 October 2021.
Revenue growth continues to be driven by demand for the Company's proprietary products, with in-house catalogue sales up approximately 37% CER on an organic basis (43% including BioVision), together with a continued recovery in global lab activity. Whilst risks related to the pandemic remain - as evidenced by the emergence of the Omicron variant in late 2021 - data indicates that, while not yet returning to pre-covid levels, overall lab activity continued to increase through 2021.
The Group has continued to build capabilities, invest in innovation and implement its multi-year growth strategy throughout the period. Overall, we anticipate adjusted operating profits will be reported in line with the board's expectations for the period and we remain on track to achieve our financial goals for the five year plan ending in 2024.
Following the change in the Company's financial year end to 31 December, full results for the 18 month period ended 31 December 2021 will be released on 14 March 2022. In order to aid comparison, pro forma information for the 12 month periods ended 31 December 2021 and 31 December 2020 will also be provided.
Alan Hirzel, CEO of Abcam commented:
"2021 was a year of significant innovation and growth in proteomic tools and discovery. I thank our customers for trusting Abcam as their preferred partner and our global colleagues for their unwavering dedication to customer needs and aspirations. Together, we are building a durable enterprise that is making a difference in the pace and social impact of discovery. I am confident in our progress toward our 2024 business goals and I look forward to providing the full update in March."
1 Incremental revenue excludes sales of BioVision products through Abcam channels
This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.
Abcam plc
+ 44 (0) 1223 696 000
James Staveley, VP Investor Relations
Numis - Nominated Adviser & Joint Corporate Broker
+ 44 (0) 20 7260 1000
Garry Levin / Freddie Barnfield / Duncan Monteith
Morgan Stanley - Joint Corporate Broker
+ 44 (0) 207 425 8000
Tom Perry / Luka Kezic
FTI C
On Trading view update says 6 of march on this site it said last week trading up date TODAY
YOU cant trust anybody lol
guess the trading statement is where boris s party results are LOL
might see some fun and games to-morrow
good download
what do you all think??
https://www.londonstockexchange.com › stock › ABC › abcam-plc › company-page
WE NEED TO CLOSE @ 12.97 OR OVER and hold for a day then up to 13 28---1349 and smash this resistance
did not expect the 1190s yesterday but still trading statement Thursday according to this site. orders have increased but profit has taken a dip, just a waiting game until it is back up to 1600
Denby, I do hope so. As they have switched their annual reporting from June to December, it was important to understand Abcam's progress, especially after the acquisition of BioVision.
Just wondering if it is safe to take flak jacket off yet..... Yesterday was pretty brutal.
trading statement Thursday :-)
This could be very interesting this could be taken over :-)
short off to day happy sorry have to go with the trend still looking to get in @12.34 ish i hope
lordloadsoflolly
Actually 1,465.706p p/s But This is a very run company and if it does go down much more than I expect, my thinking is that it might be taken over.
lordloadsoflolly
This site is the most censored site I have ever come across. I would put this on par with a child's comic book , as long as your not rude I think that you should be able to put what you like as free speech and all that in our society NOT. so if you seriously take what you read on here you will end up in a loony bin THIS site is just a bit of light entertainment I NEVER disclose what i trade if i trade or not . LOL
denby69 - not sure quite what you mean by "I was talking to another member on here". Do you not realise this is a public forum? Never mind! Anyhow, I'm highly relieved you don't give financial advice. Not that anyone's terribly likely to take it when one minute you claim to have "filled your boots" with ABCAM shares (paying around £13.60 each), then stating in the same breath that you "expect it to go down to 12.34 per share". I guess you might be proved right on the second count. Which would make your buying decision look even more daft.
I was talking to another member on here if you really want to know lordloadsoflolly earnings out soon so I guess you can make your own decisions then :-} I DO NOT GIVE ADVICE
denby69 - so you filled your boots on Monday (buying 3500 shares) when the price was around £13.60. Yet in the same breath you say - and I quote - "I still expect it to go down to 12.34 per share". Now there's some perverse logic if ever I saw it.
nice little dip this morning buy and sell this morning profit :-)
I did see that there was supposed to be a trading up date a couple of weeks ago to day well there was last year. Yes I did fill my boot yesterday and i am down a bit on 3500 shares but you should DYOR as I still expect it to go down to 12.34 per share but you would know that if you looked properly. I am waiting for that price and I will get some more.
If an RNS, for half year results, is to come today it is likely to be for the NY stock exchange opening. Let us see at 13.30.